Welcome to our dedicated page for Biolargo news (Ticker: BLGO), a resource for investors and traders seeking the latest updates and insights on Biolargo stock.
BioLargo, Inc. (OTCQX: BLGO) regularly issues news and updates about its cleantech, environmental, energy, and life sciences activities. As a developer of sustainable technologies and a full-service environmental engineering company, its announcements often focus on progress in PFAS water treatment, advanced wastewater solutions, odor and VOC control, air quality, energy storage, and medical infection control and wound care.
Recent news has highlighted BioLargo’s Aqueous Electrostatic Concentrator (AEC) platform, including reported breakthroughs that significantly reduced the system’s energy use in large-scale PFAS treatment and its deployment at a municipal drinking water facility in Lake Stockholm, New Jersey. Coverage also includes recognition of BioLargo Equipment Solutions & Technologies, Inc. in industry media for PFAS treatment advances and updates on commercial demonstration projects.
Investors and observers can also find announcements about BioLargo’s Cellinity battery technology for grid-scale energy storage, its role in broader infrastructure and clean energy discussions, and participation in conferences and investor events such as LD Micro and NobleCon. These items provide context on how the company positions its technologies within evolving infrastructure, data center, and energy investment cycles.
On the life sciences side, news items cover Clyra Medical Technologies’ progress in infection control and advanced wound care, including the ViaCLYR wound irrigation solution and its exclusive distribution alliance with Advanced Solution, LLC. Regulatory, legal, and corporate developments—such as SEC-reported events, financial updates, and intellectual property enforcement actions related to odor control technologies—are also common topics. This news page allows readers to follow BioLargo’s ongoing technical milestones, commercialization steps, and corporate disclosures in one place.
BioLargo (OTCQB:BLGO) announced key developments in its Quarterly Report on August 17, 2021, highlighting an 11% increase in consolidated revenue to $464,000 for Q2 2021. The company has made strides in commercializing PFAS treatment technology and reducing its debt by over $4 million since 2019. New contracts worth $1.2 million are expected to boost cash flow. A peer-reviewed paper validates the safety of its water treatment technology, supporting its market position. The company is actively pursuing further significant revenue opportunities.
Summary not available.
BioLargo, Inc. (OTCQB:BLGO) will host a webcast on August 17, 2021, at 8:00 am PST / 11:00 am EST, to discuss its financial results and recent events. The public is invited to participate. Replay of the webcast and teleconference will be available for a limited time on their Investor Relations webpage. BioLargo focuses on innovative technologies addressing environmental issues, such as PFAS contamination and water treatment, supported by over 80 awarded grants and numerous pilot projects. For more details, visit BioLargo's website.
BioLargo, Inc. (OTCQB:BLGO) will present at the SNN Network Summer Virtual Event 2021 on August 18 at 10 AM ET. CEO Dennis P. Calvert will discuss BioLargo's sustainable environmental technologies and engage with investors. The presentation focuses on solutions for water contamination, PFAS remediation, and air quality control. Attendees can access the presentation via a provided link. If unable to attend live, recordings will be available on the event's platform. Interested investors can also schedule one-on-one meetings with the company.
BioLargo (OTCQB:BLGO) is advancing its PFAS treatment technology, beginning tests with water samples from potential clients, including a major municipality and a federal agency in Southern California. This initial phase aims to demonstrate the effectiveness of its Aqueous Electrostatic Concentrator (AEC) system in removing PFAS contaminants. Success here could lead to larger-scale pilot programs. The recent PFAS Action Act of 2021 may enhance demand for such solutions, positioning BioLargo favorably as it boasts over 99% PFAS removal efficiency, generating significantly less waste than traditional methods.
BioLargo, Inc. (OTCQB:BLGO) announced new contract awards totaling over $1.2 million, anticipated to enhance operating cash flow and support revenue growth. The contracts involve projects with a resin manufacturing facility, a dairy farm, and a US Air Force base, among others, with most revenue expected in the next six months. CEO Dennis P. Calvert expressed optimism about the growth trajectory of their engineering subsidiary, emphasizing the potential for commercialization of patented environmental technologies.
BioLargo (OTCQB:BLGO) has announced a peer-reviewed study affirming that its Advanced Oxidation System (AOS) generates fewer disinfection by-products than conventional wastewater treatment methods. Conducted by the University of Calgary, the research indicates that AOS's by-product levels are similar to those in ordinary tap water. The technology not only enhances disinfection but also minimizes electricity consumption and effectively removes pharmaceutical micropollutants. This advancement paves the way for its commercialization in municipal wastewater treatment applications.
BioLargo, Inc. (OTCQB:BLGO) will hold its annual stockholder meeting on June 15, 2021, at 10:00 am PT via live webcast due to COVID-19 considerations. Stockholders can register online and are encouraged to vote, with eligibility based on ownership as of April 19, 2021. The meeting will feature discussions on recent annual and quarterly financial results, followed by a Q&A session. BioLargo focuses on sustainable clean technologies and environmental engineering, holding extensive patents and a variety of innovative products aimed at addressing environmental challenges.
BioLargo, Inc. (OTCQB:BLGO) will present at the LD Micro virtual event on June 9, 2021, at 5:00 PM ET. CEO Dennis P. Calvert will discuss innovative sustainable water treatment technologies, particularly targeting PFAS contamination, which poses significant health risks globally. This technology is positioned as an affordable and eco-friendly solution. The LD Micro Invitational XI will run from June 8-10, 2021, featuring around 180 companies. Interested parties can register to view the presentation here.
BioLargo (OTCQB:BLGO) announced the elimination of nearly all convertible debt, having paid off $406,000 due in August 2021. This reduction leaves only $464,000 in SBA and PPP loans and $50,000 in fixed-price convertible debt on the balance sheet. CEO Dennis Calvert noted the debt reduction from $7.6 million three years ago and highlighted a financing commitment of over $6 million. The company's environmental technologies, including the Advanced Oxidation System (AOS), are ready for commercial launch, supporting revenue growth and new partnerships.